272 related articles for article (PubMed ID: 30058959)
1. Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.
Sharma M; Hart RG; Smith EE; Bosch J; Yuan F; Casanova A; Eikelboom JW; Connolly SJ; Wong G; Diaz R; Lopez-Jaramillo P; Ertl G; Störk S; Dagenais GR; Lonn EM; Ryden L; Tonkin AM; Varigos JD; Bhatt DL; Branch KR; Probstfield JL; Kim JH; Ha JW; O'Donnell M; Vinereanu D; Fox KA; Liang Y; Liu L; Zhu J; Pogosova N; Maggioni AP; Avezum A; Piegas LS; Keltai K; Keltai M; Cook Bruns N; Berkowitz S; Yusuf S
Int J Stroke; 2019 Apr; 14(3):270-281. PubMed ID: 30058959
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.
Sharma M; Hart RG; Smith EE; Bosch J; Eikelboom JW; Connolly SJ; Dyal L; Reeh KW; Casanova A; Diaz R; Lopez-Jaramillo P; Ertl G; Störk S; Dagenais GR; Lonn EM; Ryden L; Tonkin AM; Varigos JD; Bhatt DL; Branch KRH; Probstfield JL; Kim JH; O'Donnell M; Vinereanu D; A A Fox K; Liang Y; Liu L; Zhu J; Pogosova N; Maggioni AP; Avezum A; Piegas LS; Keltai K; Keltai M; Berkowitz SD; Yusuf S
Stroke; 2020 Oct; 51(10):2901-2909. PubMed ID: 32951537
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.
Sharma M; Smith EE; Pearce LA; Perera KS; Kasner SE; Yoon BW; Ameriso SF; Puig J; Damgaard D; Fiebach JB; Muir KW; Veltkamp RC; Toni DS; Shamalov N; Gagliardi RJ; Mikulik R; Engelter ST; Bereczki D; O'Donnell MJ; Saad F; Shoamanesh A; Berkowitz SD; Mundl H; Hart RG;
Int J Stroke; 2022 Aug; 17(7):799-805. PubMed ID: 34791941
[TBL] [Abstract][Full Text] [Related]
4. Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial.
Sharma M; Smith EE; Pearce LA; Shoamanesh A; Perera KS; Coutts SB; Damgaard D; Ameriso SF; Rha JH; Modrau B; Yoon BW; Romano M; Messé SR; Barlinn J; Lambeck J; Saad F; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
Stroke; 2022 Jan; 53(1):45-52. PubMed ID: 34538089
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.
Kwan J; Hafdi M; Chiang LLW; Myint PK; Wong LS; Quinn TJ
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012269. PubMed ID: 35833913
[TBL] [Abstract][Full Text] [Related]
6. Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study.
O'Donnell MJ; Eikelboom JW; Yusuf S; Diener HC; Hart RG; Smith EE; Gladstone DJ; Sharma M; Dias R; Flaker G; Avezum A; Zhu J; Lewis G; Connolly S
Am Heart J; 2016 Aug; 178():145-50. PubMed ID: 27502862
[TBL] [Abstract][Full Text] [Related]
7. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M
JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284
[TBL] [Abstract][Full Text] [Related]
8. Silent brain infarcts impact on cognitive function in atrial fibrillation.
Kühne M; Krisai P; Coslovsky M; Rodondi N; Müller A; Beer JH; Ammann P; Auricchio A; Moschovitis G; Hayoz D; Kobza R; Shah D; Stephan FP; Schläpfer J; Di Valentino M; Aeschbacher S; Ehret G; Eken C; Monsch A; Roten L; Schwenkglenks M; Springer A; Sticherling C; Reichlin T; Zuern CS; Meyre PB; Blum S; Sinnecker T; Würfel J; Bonati LH; Conen D; Osswald S;
Eur Heart J; 2022 Jun; 43(22):2127-2135. PubMed ID: 35171989
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a randomized clinical trial evaluating the efficacy of mechanical neuroprotection in reducing the risk of silent brain infarcts associated with percutaneous left atrial appendage closure: study protocol for a LAAC-SBI trial.
Streb W; Lasek-Bal A; Mitręga K; Kowalczyk J; Podolecki T; Kowalska W; Olma A; Sobczyk A; Kalarus Z
Trials; 2023 Nov; 24(1):749. PubMed ID: 37996955
[TBL] [Abstract][Full Text] [Related]
10. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.
Bosch J; Eikelboom JW; Connolly SJ; Bruns NC; Lanius V; Yuan F; Misselwitz F; Chen E; Diaz R; Alings M; Lonn EM; Widimsky P; Hori M; Avezum A; Piegas LS; Bhatt DL; Branch KRH; Probstfield JL; Liang Y; Liu L; Zhu J; Maggioni AP; Lopez-Jaramillo P; O'Donnell M; Fox KAA; Kakkar A; Parkhomenko AN; Ertl G; Störk S; Keltai K; Keltai M; Ryden L; Dagenais GR; Pogosova N; Dans AL; Lanas F; Commerford PJ; Torp-Pedersen C; Guzik TJ; Verhamme PB; Vinereanu D; Kim JH; Ha JW; Tonkin AM; Varigos JD; Lewis BS; Felix C; Yusoff K; Steg PG; Aboyans V; Metsarinne KP; Anand SS; Hart RG; Lamy A; Moayyedi P; Leong DP; Sharma M; Yusuf S
Can J Cardiol; 2017 Aug; 33(8):1027-1035. PubMed ID: 28754388
[TBL] [Abstract][Full Text] [Related]
11. Investigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design.
Riba-Llena I; Jarca CI; Mundet X; Tovar JL; Orfila F; López-Rueda A; Nafría C; Fernández JL; Castañé X; Domingo M; Alvarez-Sabín J; Fernández-Cortiñas I; Maisterra O; Montaner J; Delgado P
BMC Neurol; 2013 Oct; 13():130. PubMed ID: 24083440
[TBL] [Abstract][Full Text] [Related]
12. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
Smith EE; Shoamanesh A; Xu L; Heenan L; Saad F; Colorado P; Chen CH; Lemmens R; De Marchis GM; Caso V; Masjuan J; Hirano T; Milanov I; Campbell BCV; Mas JL; Connolly SJ; Mundl H; Hart RG;
Stroke; 2024 Feb; 55(2):392-402. PubMed ID: 38174569
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
[TBL] [Abstract][Full Text] [Related]
16. Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.
Conen D; Rodondi N; Müller A; Beer JH; Ammann P; Moschovitis G; Auricchio A; Hayoz D; Kobza R; Shah D; Novak J; Schläpfer J; Di Valentino M; Aeschbacher S; Blum S; Meyre P; Sticherling C; Bonati LH; Ehret G; Moutzouri E; Fischer U; Monsch AU; Stippich C; Wuerfel J; Sinnecker T; Coslovsky M; Schwenkglenks M; Kühne M; Osswald S;
J Am Coll Cardiol; 2019 Mar; 73(9):989-999. PubMed ID: 30846109
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
[TBL] [Abstract][Full Text] [Related]
18. Cerebral microbleeds are not associated with long-term cognitive outcome in patients with transient ischemic attack or minor stroke.
Brundel M; Kwa VI; Bouvy WH; Algra A; Kappelle LJ; Biessels GJ;
Cerebrovasc Dis; 2014; 37(3):195-202. PubMed ID: 24557016
[TBL] [Abstract][Full Text] [Related]
19. Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease.
Coppens M; Weitz JI; Eikelboom JWA
Circ Res; 2019 Feb; 124(3):416-425. PubMed ID: 30702997
[TBL] [Abstract][Full Text] [Related]
20. External applicability of the COMPASS trial: the Western Denmark Heart Registry.
Würtz M; Olesen KKW; Thim T; Kristensen SD; Eikelboom JW; Maeng M
Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):192-199. PubMed ID: 30916315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
